Dr. Kate Newbold presents the article entitled, "Optimization of Treatment with Lenvatinib in Radioactive Iodine-Refractory Differentiated Thyroid Cancer." Dr. Culliney joins as the featured guest discussant.
0:00 Introductions
14:47 Origins of Optimization
23:34 Significant Side Effects
34:23 When to Consider Lenvatinib
Follow us on Twitter!
@thancfoundation - [ Ссылка ]
THANC on FB - [ Ссылка ]
Ещё видео!